Foresee Pharmaceuticals (Taiwan) Insiders

6576 Stock  TWD 78.50  1.50  1.95%   
Foresee Pharmaceuticals employs about 29 people. The company is managed by 23 executives with a total tenure of roughly 143 years, averaging almost 6.0 years of service per executive, having 1.26 employees per reported executive. Recap of Foresee Pharmaceuticals' management performance can provide insight into the venture performance.
Benjamin Chien  Chairman
Chairman of the Board, Acting General Manager, Chief Strategy Officer
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Foresee Pharmaceuticals Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Foresee Pharmaceuticals Management Team Effectiveness

The company has return on total asset (ROA) of (0.1768) % which means that it has lost $0.1768 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.3539) %, meaning that it generated substantial loss on money invested by shareholders. Foresee Pharmaceuticals' management efficiency ratios could be used to measure how well Foresee Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.

Foresee Pharmaceuticals Workforce Comparison

Foresee Pharmaceuticals Co is number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is presently estimated at about 720. Foresee Pharmaceuticals holds roughly 29.0 in number of employees claiming about 4% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (1.57) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.57) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.57.

Foresee Pharmaceuticals Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Foresee Pharmaceuticals Price Series Summation is a cross summation of Foresee Pharmaceuticals price series and its benchmark/peer.

Foresee Pharmaceuticals Notable Stakeholders

A Foresee Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Foresee Pharmaceuticals often face trade-offs trying to please all of them. Foresee Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Foresee Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Benjamin ChienChairman of the Board, Acting General Manager, Chief Strategy OfficerProfile
Max ChanChief Financial Officer, Head of FinanceProfile
Sheila ChuangAccounting MangProfile
Mathieu BoudreauDeputy General Manager-Business DevelopmentProfile
MengKung ChanChief OfficerProfile
John MaoSenior Deputy General ManagerProfile
Liangshang GanGeneral ManagerProfile
David LauSenior Deputy General Manager-NCE Preclinical and Clinical DevelopmentProfile
Vincent YenDirectorProfile
Sonia WuDirectorProfile
JiaLong LeeDirectorProfile
Kunhong LaiIndependent DirectorProfile
Yuhua LiDeputy General Manager-RD PipelineProfile
FuShiow YinIndependent DirectorProfile
Hank LaiIndependent DirectorProfile
Wenjin YangChief Scientific Officer, Deputy General ManagerProfile
Jagdish ParasrampuriaSenior Deputy General Manager-Drug ProductProfile
WenChi LeeIndependent DirectorProfile
Peifen ChouConsultantProfile
Ronald DadinoSenior Deputy General Manager-Pharmaceutical ManufacturingProfile
Yisheng LeeChief Medical Officer, DirectorProfile
Jeff WangDirectorProfile
Digger ChenGeneral Counsel, Deputy General ManagerProfile

About Foresee Pharmaceuticals Management Performance

The success or failure of an entity such as Foresee Pharmaceuticals often depends on how effective the management is. Foresee Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Foresee management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Foresee management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Foresee Pharmaceuticals Co., Ltd., clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in Taiwan and Europe. Foresee Pharmaceuticals Co., Ltd. was founded in 2013 and is headquartered in Taipei, Taiwan. FORESEE PHARMACEUTICALS operates under Drug ManufacturersSpecialty Generic classification in Taiwan and is traded on Taiwan OTC Exchange.
Please note, the imprecision that can be found in Foresee Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Foresee Pharmaceuticals Co. Check Foresee Pharmaceuticals' Beneish M Score to see the likelihood of Foresee Pharmaceuticals' management manipulating its earnings.

Foresee Pharmaceuticals Workforce Analysis

Traditionally, organizations such as Foresee Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Foresee Pharmaceuticals within its industry.

Foresee Pharmaceuticals Manpower Efficiency

Return on Foresee Pharmaceuticals Manpower

Revenue Per Employee7.8M
Revenue Per Executive9.8M
Net Loss Per Employee19.6M
Net Loss Per Executive24.8M

Additional Tools for Foresee Stock Analysis

When running Foresee Pharmaceuticals' price analysis, check to measure Foresee Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Foresee Pharmaceuticals is operating at the current time. Most of Foresee Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Foresee Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Foresee Pharmaceuticals' price. Additionally, you may evaluate how the addition of Foresee Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.